Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMC 3381727)

Published in J Allergy Clin Immunol on March 03, 2012

Authors

Cara J Bossley1, Louise Fleming, Atul Gupta, Nicolas Regamey, Jennifer Frith, Timothy Oates, Lemonia Tsartsali, Clare M Lloyd, Andrew Bush, Sejal Saglani

Author Affiliations

1: the Royal Brompton and Harefield NHS Trust, London, UK.

Articles citing this

Asthma across the ages: knowledge gaps in childhood asthma. J Allergy Clin Immunol (2013) 2.15

International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79

Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma. J Allergy Clin Immunol (2014) 1.61

Pathology of asthma. Front Microbiol (2013) 1.25

Pneumothorax and asthma. J Thorac Dis (2014) 1.20

IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol (2013) 1.14

Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol (2012) 1.09

Origins of increased airway smooth muscle mass in asthma. BMC Med (2013) 0.94

The complex relationship between inflammation and lung function in severe asthma. Mucosal Immunol (2014) 0.93

Clinical utility of asthma biomarkers: from bench to bedside. Biologics (2013) 0.90

The Prevalence of Serum Specific IgE to Superantigens in Asthma and Allergic Rhinitis Patients. Allergy Asthma Immunol Res (2014) 0.89

Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33. J Allergy Clin Immunol (2015) 0.88

Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders. Curr Allergy Asthma Rep (2013) 0.87

Anti-inflammatory dimethylfumarate: a potential new therapy for asthma? Mediators Inflamm (2013) 0.86

IL4 and IL-17A provide a Th2/Th17-polarized inflammatory milieu in favor of TGF-β1 to induce bronchial epithelial-mesenchymal transition (EMT). Int J Clin Exp Pathol (2013) 0.86

Future Research Directions in Asthma. An NHLBI Working Group Report. Am J Respir Crit Care Med (2015) 0.84

Asthma linked with rhinosinusitis: An extensive review. Allergy Rhinol (Providence) (2014) 0.84

GSDMB induces an asthma phenotype characterized by increased airway responsiveness and remodeling without lung inflammation. Proc Natl Acad Sci U S A (2016) 0.84

Analysis of a Panel of 48 Cytokines in BAL Fluids Specifically Identifies IL-8 Levels as the Only Cytokine that Distinguishes Controlled Asthma from Uncontrolled Asthma, and Correlates Inversely with FEV1. PLoS One (2015) 0.84

The Three A's in Asthma - Airway Smooth Muscle, Airway Remodeling & Angiogenesis. Open Respir Med J (2015) 0.82

Severe asthma in children. J Allergy Clin Immunol Pract (2014) 0.80

Endothelin-1 directs airway remodeling and hyper-reactivity in a murine asthma model. Allergy (2013) 0.80

Single systemic administration of Ag85B of mycobacteria DNA inhibits allergic airway inflammation in a mouse model of asthma. J Asthma Allergy (2012) 0.80

Exhaled nitric oxide correlates with IL-2, MCP-1, PDGF-BB and TIMP-2 in exhaled breath condensate of children with refractory asthma. Postepy Dermatol Alergol (2015) 0.80

Severe Asthma in Children: Lessons Learned and Future Directions. J Allergy Clin Immunol Pract (2016) 0.77

Bronchoalveolar lavage in infants with recurrent lower respiratory symptoms. Clin Transl Allergy (2014) 0.77

Immunohistology and remodeling in fatal pediatric and adolescent asthma. Respir Res (2017) 0.75

The cytokine interleukin-26 as a biomarker in pediatric asthma. Respir Res (2016) 0.75

Managing the pediatric patient with refractory asthma: a multidisciplinary approach. J Asthma Allergy (2017) 0.75

Biomarkers for the Phenotyping and Monitoring of Asthma in Children. Curr Treat Options Allergy (2016) 0.75

Perinatal paracetamol exposure in mice does not affect the development of allergic airways disease in early life. Thorax (2015) 0.75

Clinical characteristics of children and adolescents with severe therapy-resistant asthma in Brazil. J Bras Pneumol (2015) 0.75

Systemic Corticosteroid Responses in Children with Severe Asthma: Phenotypic and Endotypic Features. J Allergy Clin Immunol Pract (2016) 0.75

Phenotypes of severe asthma among children and adolescents in Brazil: a prospective study. BMC Pulm Med (2015) 0.75

Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran. Tanaffos (2015) 0.75

Phenotypes and endotypes of severe asthma in children. Korean J Pediatr (2013) 0.75

Vanin-1 expression and methylation discriminate pediatric asthma corticosteroid treatment response. J Allergy Clin Immunol (2015) 0.75

Biomarkers in inflammometry pediatric asthma: utility in daily clinical practice. Eur Clin Respir J (2017) 0.75

Early life allergen and air pollutant exposures alter longitudinal blood immune profiles in infant rhesus monkeys. Toxicol Appl Pharmacol (2017) 0.75

Articles cited by this

Standardisation of spirometry. Eur Respir J (2005) 48.20

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41

Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50

ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med (2005) 11.34

Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol (2004) 8.70

Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med (2009) 8.36

Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med (2002) 6.52

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med (2009) 5.90

Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol (2006) 4.80

Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med (2001) 2.87

Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide. J Allergy Clin Immunol (2006) 2.30

Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med (2007) 1.91

Severe asthma in adults. Am J Respir Crit Care Med (2005) 1.74

Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma. Am J Respir Crit Care Med (2008) 1.67

Management of severe asthma in children. Lancet (2010) 1.60

Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med (2006) 1.58

Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol (2009) 1.52

Safety and ethics of bronchoscopy and endobronchial biopsy in difficult asthma. Arch Dis Child (2001) 1.49

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest (2007) 1.46

Mechanisms controlling Th17 cytokine expression and host defense. J Leukoc Biol (2011) 1.33

Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. Eur Respir J (1998) 1.32

Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med (2008) 1.27

Th2 cytokines and asthma: an introduction. Respir Res (2001) 1.24

Airway inflammation in childhood asthma. Am J Respir Crit Care Med (2003) 1.21

Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax (2002) 1.16

The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch Dis Child (2009) 1.15

Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes. Ann Intern Med (2010) 1.13

Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma. Eur Respir J (2009) 1.13

Cytokine/anti-cytokine therapy - novel treatments for asthma? Br J Pharmacol (2011) 1.11

IL-4 receptor α polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist. J Allergy Clin Immunol (2010) 1.06

Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice. Am J Respir Cell Mol Biol (2009) 1.06

Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern. Pediatr Pulmonol (2005) 1.02

Airway remodeling is correlated with obstruction in children with severe asthma. Allergy (2008) 0.96

Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms. Thorax (2004) 0.95

T-lymphocyte functionality assessed by analysis of cytokine receptor expression, intracellular cytokine expression, and femtomolar detection of cytokine secretion by quantitative flow cytometry. Cytometry (1998) 0.92

Chronic cough in children: bronchoalveolar lavage findings. Eur Respir J (2000) 0.91

Severe childhood asthma: a common international approach? Lancet (2008) 0.87

Mepolizumab for difficult-to-control asthma with persistent sputum eosinophilia. Expert Opin Investig Drugs (2009) 0.80

Comparison of atopic and nonatopic children with chronic cough: bronchoalveolar lavage cell profile. Pediatr Pulmonol (2007) 0.79

Time required to obtain endobronchial biopsies in children during fiberoptic bronchoscopy. Pediatr Pulmonol (2009) 0.78

Articles by these authors

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39

A critical role for eosinophils in allergic airways remodeling. Science (2004) 5.53

Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med (2005) 3.48

Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12

Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. Am J Respir Crit Care Med (2011) 3.00

The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med (2011) 2.87

Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med (2008) 2.44

IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med (2010) 2.36

Longitudinal evaluation of airway function 21 years after preterm birth. Am J Respir Crit Care Med (2008) 2.35

Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med (2005) 2.26

Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol (2005) 2.22

New respiratory enterovirus and recombinant rhinoviruses among circulating picornaviruses. Emerg Infect Dis (2009) 2.16

Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med (2007) 2.09

Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med (2007) 2.08

Mutations in radial spoke head protein genes RSPH9 and RSPH4A cause primary ciliary dyskinesia with central-microtubular-pair abnormalities. Am J Hum Genet (2009) 2.07

Quality, size, and composition of pediatric endobronchial biopsies in cystic fibrosis. Chest (2007) 2.05

The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev (2011) 2.05

Rapid diagnosis of primary ciliary dyskinesia: cell culture and soft computing analysis. Eur Respir J (2012) 2.04

Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax (2012) 2.01

Activin A and TGF-β promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol (2012) 1.98

Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med (2003) 1.94

Practice imperfect--treatment for wheezing in preschoolers. N Engl J Med (2009) 1.90

Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray. J Clin Microbiol (2007) 1.89

Cortical and trabecular load sharing in the human vertebral body. J Bone Miner Res (2005) 1.88

Prevalence of asthma among Qatari schoolchildren: International Study of Asthma and Allergies in Childhood, Qatar. Pediatr Pulmonol (2006) 1.88

Of flies, mice and men: a systematic approach to understanding the early life origins of chronic lung disease. Thorax (2012) 1.88

Orchestrating house dust mite-associated allergy in the lung. Trends Immunol (2011) 1.86

Cystic fibrosis. BMJ (2007) 1.82

Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med (2008) 1.79

Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med (2009) 1.73

Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax (2011) 1.73

Lung clearance index in primary ciliary dyskinesia and bronchiectasis. Am J Respir Crit Care Med (2014) 1.73

Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med (2009) 1.72

Airway remodelling and its relationship to inflammation in cystic fibrosis. Thorax (2010) 1.67

Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros (2005) 1.67

Increased p21(CIP1/WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers. Am J Respir Crit Care Med (2002) 1.65

Sputum inflammatory phenotypes are not stable in children with asthma. Thorax (2012) 1.65

Repeatability of sodium and chloride in exhaled breath condensates. Pediatr Pulmonol (2004) 1.63

The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J Exp Med (2002) 1.62

Management of severe asthma in children. Lancet (2010) 1.60

Influence of bone volume fraction and architecture on computed large-deformation failure mechanisms in human trabecular bone. Bone (2006) 1.57

Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med (2005) 1.56

Genotyping in primary ciliary dyskinesia: ready for prime time, or a fringe benefit? Thorax (2012) 1.52

CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol (2008) 1.51

Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol (2004) 1.49

Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med (2004) 1.49

Symptom-pattern phenotype and pulmonary function in preschool wheezers. J Allergy Clin Immunol (2010) 1.48

An update on paediatric asthma. Eur Respir Rev (2012) 1.46

Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax (2010) 1.45

Does lidocaine gel alleviate the pain of bladder catheterization in young children? A randomized, controlled trial. Pediatrics (2005) 1.45

Corticosteroids in respiratory diseases in children. Am J Respir Crit Care Med (2012) 1.44

Cystic fibrosis: keeping it in the family. Pediatr Pulmonol (2002) 1.41

Basic science research vs. clinical research in cystic fibrosis: Has the pendulum swung too far? Pediatr Pulmonol (2003) 1.39

Journal policy on research funded by the tobacco industry. Thorax (2013) 1.38

Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J (2012) 1.38

Airway remodelling in children with cystic fibrosis. Thorax (2007) 1.38

Randomized, double-blind, placebo-controlled clinical trial of the efficacy of treatment with zinc or vitamin A in infants and young children with severe acute lower respiratory infection. Am J Clin Nutr (2004) 1.37

Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax (2006) 1.37

Progression of lung disease in primary ciliary dyskinesia: is spirometry less accurate than CT? Pediatr Pulmonol (2011) 1.34

Diagnosing primary ciliary dyskinesia. Thorax (2007) 1.31

The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells. Eur J Immunol (2012) 1.27

Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med (2002) 1.27

Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med (2008) 1.27

New molecular detection tools adapted to emerging rhinoviruses and enteroviruses. J Clin Microbiol (2009) 1.27

Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med (2010) 1.26

Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am J Respir Crit Care Med (2006) 1.26

IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax (2012) 1.26

Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care (2003) 1.25

Immunisation in the current management of cystic fibrosis patients. J Cyst Fibros (2005) 1.25

Chronic inflammation and asthma. Mutat Res (2009) 1.22

The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med (2004) 1.20

Phosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease. J Biol Chem (2009) 1.18

Is there still a gender gap in cystic fibrosis? Chest (2005) 1.16

Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing {gamma}{delta}T cells. Am J Respir Crit Care Med (2010) 1.15

Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am J Respir Crit Care Med (2010) 1.14

IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol (2013) 1.14

A biomechanical analysis of the effects of resorption cavities on cancellous bone strength. J Bone Miner Res (2006) 1.11

Objective monitoring of cough in children with cystic fibrosis. Pediatr Pulmonol (2002) 1.11

Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia. Pediatr Pulmonol (2005) 1.11

Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo. J Exp Med (2007) 1.08

Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma. J Allergy Clin Immunol (2009) 1.07

Long-term macrolide treatment for chronic respiratory disease. Eur Respir J (2012) 1.07

Flow-to-volume "dysanapsis" in cystic fibrosis. Am J Respir Crit Care Med (2013) 1.07